Ovarian Neoplasms: all 2,757 studies
Page 2 of 28. Open to participants first (735), then studies with results posted, then the rest; newest registration first within each.
- A Prospective Observational Study of Senaparib in the Treatment of Epithelial Ovarian CancerNot yet recruitingNCT07586449
- Application of Cardiophrenic Lymphadenectomy in Advanced Ovarian Cancer: A Single-Center Prospective Exploratory StudyRecruitingNCT07572409Not applicable
- Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian CancerRecruitingNCT07564141Phase 3
- 18F-T2 PET/CT Imaging for CAIX Positive Solid TumorsRecruitingNCT07557225Not applicable
- Enumeration and Functional Analysis of Circulating Tumor Cells for Homologous Recombination: a Prospective Single-center Study on Advanced/Metastatic Solid TumorsNot yet recruitingNCT07555600Not applicable
- Tiaoshen Anti-cancer Protocol and CBT for Insomnia and Survival in Ovarian CancerNot yet recruitingNCT07550205Phase 2/3
- Setting Up ctDNA Analysis on Archived Plasma SamplesRecruitingNCT07546578
- A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein ExpressionRecruitingNCT07546500Phase 3
- A Randomized Controlled Trial Evaluating the Feasibility and Preliminary Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Advanced Epithelial Ovarian CancerRecruitingNCT07544030Phase 3
- Survival Analysis in patiEnts With Bad Prognosis Epithelial Ovarian CArcinomaRecruitingNCT07540403
- Study to Assess Prevalence of the Folate Receptor Alpha (FRa) in Adult Female Participants With Ovarian Cancer in Intercontinental (InterCon) CountriesRecruitingNCT07539844
- A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian CancerRecruitingNCT07532434
- Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal CancerNot yet recruitingNCT07532148Phase 1
- Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid TumorsRecruitingNCT07524322Phase 1
- Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid TumorsRecruitingNCT07523529Phase 1/2
- Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid TumorsRecruitingNCT07517198Phase 1
- Efficacy and Safety of CapsuleX Combined With Cisplatin in Platinum-Resistant Recurrent Ovarian Cancer: A Single-Arm Prospective Clinical StudyRecruitingNCT07495384Not applicable
- IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of RecurrenceRecruitingNCT07495124Phase 2
- EARLY Study: Evaluating the Specificity and Feasibility of the EARLY Biomarker Panel for Ovarian Cancer DetectionRecruitingNCT07491081Not applicable
- Benmelstobart in Combination With Anlotinib and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Epithelial OvariaN, Fallopian Tube, or Primary Peritoneal CancerNot yet recruitingNCT07489300Phase 2
- GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube CancerRecruitingNCT07489287Phase 1
- Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16)RecruitingNCT07480954Phase 1/2
- TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk PatientsRecruitingNCT07480785Not applicable
- PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal CancerRecruitingNCT07472140Phase 2/3
- A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.RecruitingNCT07470853Phase 1
- A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer RisksRecruitingNCT07469709
- CYTALUX Dose Extension StudyNot yet recruitingNCT07469202Phase 4
- Updating the EORTC Quality-of-Life Questionnaire for Ovarian Cancer (QLQ-OV38)Not yet recruitingNCT07465133
- A Phase 1 Clinical Study to Evaluate the Safety and Efficacy of WSK-IM02 in Patients With Platinum-resistant Recurrent Ovarian Cancer.Not yet recruitingNCT07462468Phase 1
- The PROOV Study: Exploiting the Synergistic Effect of PARP Inhibition With Cisplatin and Hyperthermia During Interval Cytoreductive Surgery and HIPEC in Ovarian CancerRecruitingNCT07460180Phase 1/2
- A Single-center, Dose-escalation Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of Tumor Neoantigen-pulsed Autologous Dendritic Cell Injection (YS247) in Study Participants With HRD-negative Epithelial Ovarian CancerNot yet recruitingNCT07455071Not applicable
- Iparomlimab/Tuvonralimab + Standard Chemotherapy and Olaparib in Platinum-Sensitive Recurrent Ovarian CancerNot yet recruitingNCT07454018Phase 2
- QLS5132 Combination Therapy in Advanced Solid TumorsNot yet recruitingNCT07453394Phase 1/2
- Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot TrialRecruitingNCT07447050Phase 2
- A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low ExpressionNot yet recruitingNCT07446049Phase 2
- Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid TumorsRecruitingNCT07444814Phase 1
- DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.RecruitingNCT07440290Phase 2/3
- WellSpan-THRIVE Cancer QOL StudyRecruitingNCT07433660
- An Exploratory Study of Detection of Endometrial and Ovarian Cancers in Vaginal Samples Retrieved by the Ellele Sampling DeviceNot yet recruitingNCT07429799Not applicable
- Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid TumorsRecruitingNCT07424547Phase 1
- An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.Not yet recruitingNCT07420010Early Phase 1
- EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid TumorsRecruitingNCT07410676Phase 1/2
- Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid TumorsRecruitingNCT07410494Phase 1/2
- Iparomlimab and Tuvonralimab (QL1706) Combined With Standard Chemotherapy or Combined With Intraperitoneal Perfusion Chemotherapy and Olaparib as Neoadjuvant Therapy for Advanced Ovarian CancerNot yet recruitingNCT07407452Phase 2
- A Study to Evaluate Folate Receptor Alpha (FRα) Expression in Adult Participants With Ovarian, Fallopian Tube, and Primary Peritoneal Cancer in ItalyRecruitingNCT07407062
- Navigation Intervention for Adolescent and Young Adult Cancer SurvivorsRecruitingNCT07406087Not applicable
- INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)RecruitingNCT07403630Not applicable
- Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube CancerRecruitingNCT07402915Phase 1
- The Efficacy and Safety of Paclitaxel Monotherapy Versus Paclitaxel-Carboplatin Combination as Neoadjuvant Chemotherapy in Advanced Ovarian Cancer With High PARK2 ExpressionNot yet recruitingNCT07401654Phase 2
- A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.RecruitingNCT07389239Phase 1/2
- Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic TestingRecruitingNCT07387263Not applicable
- The Role of Blood Perfusion in Cervical Cancer, Cervical Intraepithelial Neoplasm and Ovarian Cancer PatientsNot yet recruitingNCT07385976
- Fluzoparib Plus Famitinib Maintenance After First-Line Platinum Response in Advanced Ovarian CancerNot yet recruitingNCT07382713Phase 2
- NeoAdjuvant ChemoTherapy With KELIM Guided Interval vs. Delayed Interval Debulking SurgeryNot yet recruitingNCT07382479Not applicable
- Bioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian CancerRecruitingNCT07371104Phase 1
- To Evaluate the Efficacy and Safety of JPI-547 in Combination With Bevacizumab as Maintenance Therapy in Relapsed Ovarian CancerNot yet recruitingNCT07370818Phase 2
- Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receiving Chemotherapy Improvement of Peripheral Neuropathy and Quality of LifeNot yet recruitingNCT07362147Not applicable
- Identification of Genetic, Phenotypic, Clinical, Biological and Histological Factors Differentiating Patients With Ovarian Cancer Who Are Refractory to Platinum-based Therapy From Patients Defined as Long-term Responders to Platinum-based TherapyRecruitingNCT07361471Not applicable
- Anti-Ly6E Exatecan ADC M7437 in Advanced Solid TumorsRecruitingNCT07360314Phase 1
- A Randomized, Open-label, Double-cohort Study of Fluzoparib Combined With Famitinib Malate or SHR-1701 for Neoadjuvant Therapy in Patients With Advanced Ovarian CancerNot yet recruitingNCT07355010Phase 2
- SL-28 for Advanced Solid TumoursRecruitingNCT07341737Phase 1/2
- Trastzumab Deruxtecan Versus SOC in Recurrent Ovarian That Progressed on Prior PARP Inhibitor TherapyRecruitingNCT07340164Phase 2
- Surgeons' Ability to Predict Pathological and Molecular Features of Peritoneal Carcinomatosis in Ovarian CancerNot yet recruitingNCT07321730
- A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)RecruitingNCT07318558Phase 3
- Sample Collection for Ongoing Research and Product Evaluation StudyRecruitingNCT07318051
- A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)RecruitingNCT07306559Phase 1
- A Study of PLB-002 in Advanced Solid TumorsRecruitingNCT07304128Phase 1
- A Study of Isoquercetin in People With Ovarian CancerRecruitingNCT07303894Phase 2
- Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors.RecruitingNCT07303387Phase 2
- Survivors Uniting for Remote Guided ExerciseRecruitingNCT07290309Not applicable
- A Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)RecruitingNCT07286266Phase 3
- Trauma-Focused Managing Cancer And Living Meaningfully (CALM-TF) for Newly Diagnosed and Recurrent Ovarian CancerNot yet recruitingNCT07286162Phase 3
- Efficacy and Safety of Distamab Vedotin Combined With Carboplatin for Advanced Ovarian Cancer in the First Line TreatmentRecruitingNCT07285941Phase 2
- The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasRecruitingNCT07285044Phase 2
- Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology CliniciansRecruitingNCT07282158Not applicable
- Ultrasound Microvessel Imaging for the Evaluation of Ovarian and Adnexal LesionsRecruitingNCT07280312Not applicable
- A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian CancerRecruitingNCT07278336Phase 1
- Tolerance, Safety, Efficacy, and Pharmacokinetics of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel for Platinum-resistant Recurrent Ovarian CancerNot yet recruitingNCT07273396Phase 1/2
- PONDER: Pelvic Peritonectomy in Early Stage Ovarian TumorsNot yet recruitingNCT07271914Not applicable
- Impact of Dietary Patterns on Prognosis of Ovarian Cancer Patients During PARPi MaintenanceNot yet recruitingNCT07269574
- Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases.Not yet recruitingNCT07267780
- Phase II Study of Weekly Paclitaxel/Nab-Paclitaxel, Pembrolizumab, and Mirabegron for Recurrent Ovarian CancerRecruitingNCT07261683Phase 2
- A Study of DEG6498 in Participants With Solid TumorsRecruitingNCT07244835Phase 1
- Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Cell CarcinomaNot yet recruitingNCT07239622Phase 2
- A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid TumorsRecruitingNCT07229313Phase 1
- A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian CancerRecruitingNCT07226427Phase 1
- Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet ChemotherapyRecruitingNCT07225270Phase 3
- The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.RecruitingNCT07224464Not applicable
- The Better, Harder, Faster, Stronger StudyRecruitingNCT07220512
- Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)RecruitingNCT07219238Phase 2/3
- FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid TumorsRecruitingNCT07216105Phase 1
- Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 OverexpressionRecruitingNCT07214779Phase 3
- A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian CancerRecruitingNCT07213804Phase 3
- A Study of LY4337713 in Participants With FAP-Positive Solid TumorsRecruitingNCT07213791Phase 1
- No-Stoma Policy in Advanced Ovarian Cancer SurgeryRecruitingNCT07213193Not applicable
- Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer PatientsRecruitingNCT07211659Phase 1
- 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid TumorsRecruitingNCT07189871Phase 1/2
- A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9RecruitingNCT07186842Phase 1/2
- EXoPERT EMERALD Clinical StudyRecruitingNCT07186296
- A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid TumorsRecruitingNCT07182149Phase 1